Brexpiprazole 5mg
Brexpiprazole is a novel D2 dopamine partial agonist investigational product currently in clinical trials for the treatment of depression, schizophrenia, and attention deficit hyperactivity disorder (ADHD).
| Trivial name | Brexpiprazole 5mg |
| Catalog Number | A13527-5 |
| Alternative Name(s) | 2(1H)-Quinolinone, 7-(4-(4-benzo(b)thien-4-yl-1-piperazinyl)butoxy)- |
| Molecular Formula | C25H27N3O2S |
| CAS# | 913611-97-9 |
| SMILES | C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4 |
| Size | 5mg |
| Supplier Page | http://www.adooq.com/brexpiprazole.html |